A detailed history of Simplex Trading, LLC transactions in Arcturus Therapeutics Holdings Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 1,381 shares of ARCT stock, worth $22,123. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,381
Holding current value
$22,123
% of portfolio
0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$18.08 - $25.38 $24,968 - $35,049
1,381 New
1,381 $32,000
Q4 2022

Feb 02, 2023

BUY
$14.14 - $23.06 $43,466 - $70,886
3,074 Added 352.93%
3,945 $66,000
Q3 2022

Nov 04, 2022

BUY
$13.05 - $22.13 $11,366 - $19,275
871 New
871 $12,000
Q2 2022

Aug 03, 2022

SELL
$12.26 - $31.17 $241,644 - $614,360
-19,710 Closed
0 $0
Q1 2022

May 02, 2022

BUY
$17.64 - $39.57 $235,299 - $527,824
13,339 Added 209.37%
19,710 $531,000
Q4 2021

Feb 23, 2022

BUY
$34.2 - $47.56 $190,459 - $264,861
5,569 Added 694.39%
6,371 $235,000
Q3 2021

Oct 28, 2021

SELL
$27.88 - $58.25 $35,491 - $74,152
-1,273 Reduced 61.35%
802 $28,000
Q2 2021

Aug 12, 2021

SELL
$25.79 - $42.11 $192,393 - $314,140
-7,460 Reduced 78.24%
2,075 $70,000
Q1 2021

Apr 26, 2021

BUY
$38.75 - $86.92 $334,993 - $751,423
8,645 Added 971.35%
9,535 $393,000
Q4 2020

Feb 02, 2021

BUY
$34.61 - $123.66 $30,802 - $110,057
890 New
890 $38,000
Q3 2020

Oct 14, 2020

SELL
$37.49 - $63.19 $3,149 - $5,307
-84 Closed
0 $0
Q2 2020

Jul 13, 2020

SELL
$12.66 - $58.27 $39,752 - $182,967
-3,140 Reduced 97.39%
84 $3,000
Q1 2020

Apr 29, 2020

SELL
$9.31 - $18.26 $93,733 - $183,841
-10,068 Reduced 75.74%
3,224 $43,000
Q4 2019

Feb 05, 2020

BUY
$8.93 - $12.41 $7,786 - $10,821
872 Added 7.02%
13,292 $144,000
Q3 2019

Oct 15, 2019

BUY
$8.8 - $14.5 $87,991 - $144,985
9,999 Added 413.01%
12,420 $127,000
Q2 2019

Jul 26, 2019

BUY
$5.78 - $9.79 $13,993 - $23,701
2,421 New
2,421 $22,000

Others Institutions Holding ARCT

About Arcturus Therapeutics Holdings Inc.


  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $426M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Simplex Trading, LLC Portfolio

Follow Simplex Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.